Boxed Warnings, Drug Watch Are Policy Goals Of Drug Safety Oversight Board

FDA's Drug Safety Oversight Board should start shifting its focus toward broader policy questions - like standards for boxed warnings - in addition to addressing emerging safety issues for specific products, DSOB Executive Director Susan Cummins suggested